Evolent Health (Germany) Market Value
| 9EH Stock | EUR 10.70 0.30 2.73% |
| Symbol | Evolent |
Evolent Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evolent Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evolent Health.
| 12/04/2022 |
| 11/23/2024 |
If you would invest 0.00 in Evolent Health on December 4, 2022 and sell it all today you would earn a total of 0.00 from holding Evolent Health or generate 0.0% return on investment in Evolent Health over 720 days. Evolent Health is related to or competes with Superior Plus, NMI Holdings, Origin Agritech, SIVERS SEMICONDUCTORS, Talanx AG, and NorAm Drilling. Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in... More
Evolent Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evolent Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evolent Health upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 51.24 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 4.55 |
Evolent Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evolent Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evolent Health's standard deviation. In reality, there are many statistical measures that can use Evolent Health historical prices to predict the future Evolent Health's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.22) | |||
| Total Risk Alpha | (2.04) | |||
| Treynor Ratio | (0.98) |
Evolent Health Backtested Returns
Evolent Health secures Sharpe Ratio (or Efficiency) of -0.23, which denotes the company had a -0.23% return per unit of risk over the last 3 months. Evolent Health exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Evolent Health's Standard Deviation of 6.11, variance of 37.36, and Mean Deviation of 3.41 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.1, which means a somewhat significant risk relative to the market. Evolent Health returns are very sensitive to returns on the market. As the market goes up or down, Evolent Health is expected to follow. At this point, Evolent Health has a negative expected return of -1.33%. Please make sure to confirm Evolent Health's information ratio, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Evolent Health performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.25 |
Poor predictability
Evolent Health has poor predictability. Overlapping area represents the amount of predictability between Evolent Health time series from 4th of December 2022 to 29th of November 2023 and 29th of November 2023 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evolent Health price movement. The serial correlation of 0.25 indicates that over 25.0% of current Evolent Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.25 | |
| Spearman Rank Test | 0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 22.51 |
Evolent Health lagged returns against current returns
Autocorrelation, which is Evolent Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Evolent Health's stock expected returns. We can calculate the autocorrelation of Evolent Health returns to help us make a trade decision. For example, suppose you find that Evolent Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Evolent Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Evolent Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Evolent Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Evolent Health stock over time.
Current vs Lagged Prices |
| Timeline |
Evolent Health Lagged Returns
When evaluating Evolent Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Evolent Health stock have on its future price. Evolent Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Evolent Health autocorrelation shows the relationship between Evolent Health stock current value and its past values and can show if there is a momentum factor associated with investing in Evolent Health.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Evolent Stock
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:Check out Evolent Health Correlation, Evolent Health Volatility and Evolent Health Alpha and Beta module to complement your research on Evolent Health. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Evolent Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.